Literature DB >> 15206503

Tuberculous meningitis in adults--experience from Turkey.

A A Cagatay1, H Ozsut, L Gulec, S Kucukoglu, H Berk, N Ince, B Ertugrul, S Aksoz, D Akal, H Eraksoy, S Calangu.   

Abstract

BACKGROUND: The annual incidence of tuberculous meningitis (TM) is unknown. TM is a disease that still often results in residual sequelae, and has a mortality rate ranging between 15 and 51%. Experience of countries such as Turkey where drug-resistant tuberculosis and TM are prevalent is important.
METHODS: Clinical and laboratory findings of 42 patients with TM, followed between 1991 and 2002, were evaluated retrospectively.
RESULTS: Twenty-eight female and 14 male patients were included in this study. The mean age of the patients was 33.9 +/- 13.2 years (range, 16-60 years). Fourteen had a history of pulmonary tuberculosis; 12 reported close contact with a person with active pulmonary tuberculosis; three were diagnosed with active pulmonary tuberculosis; two, with HIV infection; two, with Pott's disease; and one, with systemic lupus erythematosus. On admission, 17 patients were diagnosed with stage I; 15, with stage II; and 10, with stage III disease. Hemiparesis (35.7%), cranial nerve palsy (30.9%), and altered consciousness (26.9%) were the most common neurological deficits. Prolonged duration of pre-existing symptoms and female gender were found as significant risk factors in those who develop neurological sequelae (p < 0.01 and p < 0.05, respectively). Cranial computerised tomography revealed various pathological findings in all but five patients. Sulcus effacement was the most common radiological finding. Enlargement of ventricles, focal cerebral oedema/shunt, calcification of meninges, tubercle, and infarction were other common abnormal radiological findings.
CONCLUSIONS: Prolonged duration of pre-existing symptoms and female gender are predictors of neurological sequelae of TM. Early identification of such patients and prompt initiation of anti-tuberculosis therapy may improve their outcome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15206503     DOI: 10.1111/j.1368-5031.2004.00148.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  6 in total

1.  Presentation and outcome of tuberculous meningitis in adults in the province of Castellon, Spain: a retrospective study.

Authors:  B Roca; N Tornador; E Tornador
Journal:  Epidemiol Infect       Date:  2008-01-21       Impact factor: 2.451

2.  Neurobrucellosis with transient ischemic attack, vasculopathic changes, intracerebral granulomas and basal ganglia infarction: a case report.

Authors:  Asuman Sengoz Inan; Nurgul Ceran; Ilknur Erdem; Derya O Engin; Seniha Senbayrak; Seyfi C Ozyurek; Pasa Goktas
Journal:  J Med Case Rep       Date:  2010-10-25

3.  Treatment outcomes of tuberculous meningitis in adults: a systematic review and meta-analysis.

Authors:  Ming-Gui Wang; Lan Luo; Yunxia Zhang; Xiangming Liu; Lin Liu; Jian-Qing He
Journal:  BMC Pulm Med       Date:  2019-11-06       Impact factor: 3.317

4.  Global Frequency and Clinical Features of Stroke in Patients With Tuberculous Meningitis: A Systematic Review.

Authors:  Marie Charmaine C Sy; Adrian I Espiritu; Jose Leonard R Pascual
Journal:  JAMA Netw Open       Date:  2022-09-01

5.  Tuberculous meningitis in adults in the terms of tertiary prevention: review of 22 cases.

Authors:  Zohreh Aminzadeh; Tahereh Mahmoodi
Journal:  Int J Prev Med       Date:  2013-04

6.  Treatment Outcomes in Adult Tuberculous Meningitis: A Systematic Review and Meta-analysis.

Authors:  Anna M Stadelman; Jayne Ellis; Thomas H A Samuels; Ernest Mutengesa; Joanna Dobbin; Kenneth Ssebambulidde; Morris K Rutakingirwa; Lillian Tugume; David R Boulware; Daniel Grint; Fiona V Cresswell
Journal:  Open Forum Infect Dis       Date:  2020-06-30       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.